ADHD, or Attention-Deficit/Hyperactivity Disorder, has become one of the most diagnosed and discussed neurodevelopmental disorders in recent decades. As diagnoses have soared, so too has the spotlight on treatments, primarily in the form of medications. But who funds the research that brings these treatments to market? As is common in the medical industry, pharmaceutical companies—referred to colloquially as "big pharma"—often play a major role in funding ADHD research. This has raised qu...
Continue reading...
